Schedule to meet with Catalent at CAR-TCR Digital Summit Europe

Date: February 16-18, 2021
Location: Virtual Conference
Booth: Catalent

FEATURED SPEAKER

Dr. Jef Pinxteren
Director of Process and Analytical Development, Catalent Cell and Gene Therapy

Session Title: Moving to Commercial Readiness with an Analytical Dedicated Platform for T-cell Therapies
Date:  Wednesday, February 17, 2021
Time: 4:30pm-5:00pm GMT
Abstract: Dr. Jef Pinxteren, Director of Process and Analytical Development at Catalent Cell and Gene Therapy, will discuss a breadth of analytical methodologies facilitating manufacturing design and accelerate CAR-T therapies to commercial readiness phase.

Attendees will be able to gain insight into:

• • Benefits of working with a full-service provider of analytical methods
  • Strategy and process flow from analytical assay development to GMP implementation for clinical and commercial manufacturing
  • Approaches to control clinical and commercial manufacturing process steps to obtain highest quality cell therapy products
  • Emerging strategies for cell therapy product identification, characterization and potency testing using state-of-the-art technologies
  • Definition of framework for analytical method validation ensuring fast batch release